About this trial
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care.
Actively working during the data collection period.
Disqualifiers
Administrative staff and personnel not directly involved in patient care.
HCP who declined to participate.
Participants who did not complete the questionnaire in full.
Trial population
Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"
Trial design
Other
Cross-sectional
Treatments tested in this trial
Questionnaire assessing knowledge on diabetes technology
Other interventionA standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies
Treatment groups
Trial outcomes
Primary outcomes
Knowledge of Diabetes Mellitus aspects
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
Secondary outcomes
knowledge on insulin use
The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.
Knowledge of healthcare professionals on continuous glucose monitoring systems
Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.